Cyclosporin-induced hypertension: incidence, pathogenesis and management.
about
Association between Psoriasis and Cardiovascular Risk Factors in Korean Patients.Management of Corneal Graft Rejection - A Case Series Report and Review of the LiteraturePsoriasis and high blood pressure.Drug interactions and drugs that affect blood pressure.Antihypertensive agents and renal transplantation.Hypertension in rheumatoid arthritis.A 16 Month Survey of Cyclosporine Utilization Evaluation in Allogeneic Hematopoietic Stem Cell Transplant Recipients.Accidental Overdose of Oral Cyclosporine in Haematopoietic Stem Cell Transplantation: A Case Report and Literature Review.PP2B-dependent NO production in the medullary thick ascending limb during diabetes.Hypertension after pediatric cardiac transplantation: detection, etiology, implications and management.Angiotensin Type-2 (AT-2)-Receptor activation reduces renal fibrosis in cyclosporine nephropathy: Evidence for blood-pressure independent effect.Mitochondrial injury and dysfunction in hypertension-induced cardiac damage.Prevention of nephrotoxicity induced by cyclosporine-A: role of antioxidants.Central modulation of cyclosporine-induced hypertension.Synthetic pharmacotherapy for lupus nephritis.Adverse effects of low-dose systemic cyclosporine therapy in high-risk penetrating keratoplasty.Long-term exposure to belatacept in recipients of extended criteria donor kidneys.Left ventricle geometry remolding after heart transplantation: a two-dimensional ultrasound study.Amelioration of cyclosporine nephrotoxicity by irbesartan, A selective AT1 receptor antagonist.Protective effect of curcumin on cyclosporin A-induced endothelial dysfunction, antioxidant capacity, and oxidative damage.Early development of metabolic syndrome in patients subjected to lung transplantation.Photobleaching-based method to individualize irradiation time during interstitial 5-aminolevulinic acid photodynamic therapy.Hydrocortisone attenuates cyclosporin A-induced nephrotoxicity in rats
P2860
Q34050825-8B20F968-C098-4D3E-BB71-268F7FBA1548Q35069798-61DCB930-7565-4057-AB81-B9250289ED39Q35262970-8F6E0E74-E173-4C05-B7F0-78EDBC5BF06DQ36617766-426A8663-93E4-4AF3-99FC-1BBE9C8DFD14Q36765942-88933845-61E0-4BD9-8F08-67C1B5576449Q37158219-B3114A35-56CA-4358-8CDF-8A9C37D2ECA8Q37178100-132F57A1-3771-4BE1-A516-F9DAE77353CAQ37219133-194F65D0-C889-4E93-82C8-69A7E50BA73AQ37298520-3C6F22AD-4083-4668-8786-659483376F4FQ37558668-F55FAA74-CFCA-41F2-BB88-E876E4C43338Q37626862-307EA01B-3042-447C-83E8-D77AF06279C3Q38266758-7B00AC52-1EEB-4A2F-8AB6-5E07DC2288C6Q38270703-A25267C1-00B6-4B12-8743-A42C2EB78DE6Q38272109-B4A64579-6438-4AE7-81C7-09372DF76F34Q39064602-FB1B2554-B98D-48A6-AB42-48166744E3ACQ41304358-9740E2BC-EE2E-45B0-B746-F8D9C41407F7Q42264108-47E3E19B-8A13-4BA9-9231-C645D2CCF6CBQ44169590-D6C02727-3FD4-4AC5-8842-C4597E0B484DQ45139503-7E5E4F72-28C4-442F-9124-5AE107E0D821Q45272269-822E9764-837A-4C20-9783-96B6C058CB8BQ46148440-66C5AD9A-224F-43CE-8982-9D6E24841A8BQ48934431-97E1339A-9EB9-427C-B074-5ECE89373B82Q57652470-3597D11D-F6F3-41A2-A1DF-A351874D416E
P2860
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
@ast
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
@en
type
label
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
@ast
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
@en
prefLabel
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
@ast
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
@en
P2093
P1433
P1476
Cyclosporin-induced hypertension: incidence, pathogenesis and management.
@en
P2093
L Schwartz
S C Textor
V J Canzanello
P304
P356
10.2165/00002018-199920050-00004
P577
1999-05-01T00:00:00Z
P6179
1004868221